Supplementary Figure 2.tif (495.02 kB)

Supplementary Figure 2: Development and validation of an immune gene-set based prognostic signature in cutaneous melanoma.tif

figure

posted on 2021-07-22, 11:02 authored by Qi TianQi Tian, Huan Gao, Wen Zhao, Yan Zhou, Jin Yang

Supplementary figure 2 - Development and validation of an immune gene-set based prognostic signature in cutaneous melanoma

Prediction of response to cancer immunotherapy of melanoma patients receiving anti-PD1 (A) and anti-CTLA4 (B) treatment according to the TIDE website.

Funding

This study was supported by International Cooperation Foundation Project of Shaanxi Province (No. 2019KW-033) and Clinical Research Project of the First Affiliated Hospital of Xi'an Jiaotong University (XJTU1AF-CRF-2016-020).

History

Usage metrics

Read the peer-reviewed publication

Development and validation of an immune gene-set based prognostic signature in cutaneous melanoma

Future Science Group

Keywords

cutaneous melanoma tumor microenvironment prognosis immunotherapeutic response TCGA GEO Cancer Genetics

Licence

CC BY-NC-ND 4.0